InvestorsHub Logo
Followers 145
Posts 27558
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 190

Tuesday, 07/06/2021 9:30:52 AM

Tuesday, July 06, 2021 9:30:52 AM

Post# of 239
AgPlenus highlights encouraging Proof of Concept testing results from APH1

Jul. 06, 2021 9:25 AM ETEvogene Ltd. (EVGN)

By: Aakash Babu, SA News Editor

Evogene (NASDAQ:EVGN) subsidiary AgPlenus has achieved positive results in a Proof of Concept (POC) testing of a resistance trait for its leading novel Mode-of-Action ((MoA)) herbicide product candidate APH1.

The company highlighted that, in earlier studies, APH1 demonstrated effective control over a broad panel of weeds at commercial dose rates, including control over weeds that are known to have resistance to existing herbicides.

The next step in the development of a resistance trait is to attempt to modify soybean plants to establish resistance to APH1, AgPlenus said.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News